Clinical Trial Update: tSCS and 5-Azacitidine for Enhanced Motor Outcomes in Cerebral Palsy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of transcutaneous spinal cord stimulation (tSCS) and 5-azacitidine to improve motor outcomes in cerebral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• 5-Azacitidine (azacitidine)
• Transcutaneous Spinal Cord Stimulation (transcutaneous spinal cord stimulation)

Snippet

Sponsor: Shirley Ryan AbilityLab | Conditions: Cerebral Palsy | Phase 2 | Status: NOT_YET_RECRUITING